Answers are grounded in this paper and cite their sources.
This analysis emphasizes the need for integrative multi-omics approaches to monitor pregnant women with IBD, suggesting personalized care.
We emphasize that the persistent focus on isolated biomarkers is unlikely to meet the complexity of pregnancy in patients with IBD. Instead, we propose that integrative multi-omics approaches capturing interacting biological processes represent a more conceptually sensible path forward. While rigorous prospective validation and standardization are essential before clinical implementation, such strategies hold promise for more personalized risk stratification and monitoring of pregnant patients with IBD.
No takes yet. Share an insight, caveat, or question.
Holstein et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: